CVRx, Inc. (CVRX) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

Earnings Reports

• CVRX (CVRX) Q4 2025: Category 1 CPT Code Unlocks 46% Medicare Advantage Approval, Setting Stage for Growth Acceleration
  June 15, 2026
• CVRX (CVRX) Q1 2026: U.S. Heart Failure Revenue Climbs 22% as Barostim Adoption Expands
  May 12, 2026
• CVRX (CVRX) Q3 2025: Gross Margin Rises 400bps as Barostim Adoption Deepens
  November 06, 2025
• CVRX (CVRX) Q2 2025: 35% New Sales Hires Drive Account Expansion, Reimbursement Tailwinds Build
  August 04, 2025
• CVRX (CVRX) Q1 2025: 25% Sales Team Overhaul Drives Transition, Productivity Ramp Key to H2 Recovery
  July 05, 2025

Browse all companies